Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin.

@article{McDonell2015ReceptorTK,
  title={Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin.},
  author={Laura M McDonell and Kristin D. Kernohan and Kym M. Boycott and Sarah L. Sawyer},
  journal={Human molecular genetics},
  year={2015},
  volume={24 R1},
  pages={
          R60-6
        }
}
Receptor tyrosine kinases (RTKs) are a family of ligand-binding cell surface receptors that regulate a wide range of essential cellular activities, including proliferation, differentiation, cell-cycle progression, survival and apoptosis. As such, these proteins play an important role during development and throughout life; germline mutations in genes encoding RTKs cause several developmental syndromes, while somatic alterations contribute to the pathogenesis of many aggressive cancers. This… 

Figures and Tables from this paper

Mechanisms of receptor tyrosine kinase activation in cancer

The processes whereby RTKs are activated under normal physiological conditions are reviewed and several mechanisms wherebyRTKs can be aberrantly activated in human cancers are discussed.

Assessment of fibroblast growth factor receptor cancer-associated mutations and characterisation of endocrine signalling complexes

It was found that hyperactive mutations did not necessarily occur frequently and conversely, frequently occurring mutation 'hotspots' were not necessarily kinase hyperactive, reinforcing the importance of screening clinical tumours prior to treatment to provide better data-driven therapies for patients.

Receptor Tyrosine Kinases in Development: Insights from Drosophila

The functions of several RTKs that govern distinct cell-fate decisions in Drosophila are highlighted and how their activities are developmentally controlled is explored.

Role of tyrosine kinases in bladder cancer progression: an overview

All of the reported tyrosine-kinases which have been significantly associated with the clinicopathological features of BCa patients are summarized and the molecular biology of tyrosines during BCa progression and metastasis is clarified.

Role of Tyrosine Kinase Receptors in Growth Factor Mediated Signal Transduction, with Specific Reference to MAPK/Rasand p13k-Akt Containing Pathways in Oncogenesis: A Qualitative Database Review

Receptor Tyrosine kinases (RTKs) play a crucial role in the signal transduction pathways at cellular levels and regulates different functions of the cell, such as cellular growth, differentiation, metabolism and motility.

Primary Cilia and Coordination of Receptor Tyrosine Kinase (RTK) and Transforming Growth Factor β (TGF-β) Signaling.

An overview of primary cilia-mediated regulation of receptor tyrosine kinase (RTK) and transforming growth factor β (TGF-β) signaling is presented and how defects in the coordination of these pathways may be linked to ciliopathies is discussed.

Eph receptor signalling: from catalytic to non-catalytic functions

A structural perspective of the intricate molecular mechanisms that drive Eph receptor signalling is provided, and the contribution of intra- and inter-molecular interactions between Eph receptors intracellular domains and their major binding partners is investigated.

Conserved Roles for Receptor Tyrosine Kinase Extracellular Regions in Regulating Receptor and Pathway Activity

It is shown that deletion of the extracellular regions of 10 RTKs representing 7 RTK classes or their substitution with the dimeric immunoglobulin Fc region results in constitutive receptor phosphorylation but fails to result inosphorylation of downstream signaling effectors Erk or Akt.

References

SHOWING 1-10 OF 61 REFERENCES

The RET proto-oncogene in human cancers

The identification of RET mutations in most MEN 2 families (95%) has translated into improved care for MEN 2 patients, and further investigation of the signaling pathways contributing to tumorigenesis in relevant tissues will eventually help to develop novel strategies to prevent or to treat human papillary thyroid carcinomas, MEN 2 disease, as well as the sporadic cancers relevant to MEN2 disease.

Targeting mutant fibroblast growth factor receptors in cancer.

Cancer driver mutations in protein kinase genes.

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma.

FGFR3, when overexpressed in MM, may be not only oncogenic when stimulated by FGF ligands in the bone marrow microenvironment, but is also a target for activating mutations that enable FGFR3 to play a ras-like role in tumor progression.

Drug-sensitive FGFR2 mutations in endometrial carcinoma

It is shown that somatic mutations of the fibroblast growth factor receptor 2 (FGFR2) tyrosine kinase gene, FGFR2, are present in 12% of endometrial carcinomas, with additional instances found in lung squamous cell carcinoma and cervical carcinoma.

Cell Signaling by Receptor Tyrosine Kinases

Spatial regulation of receptor tyrosine kinases in development and cancer

The realization that spatial deregulation of RTKs is likely to contribute broadly to cancer development and may affect the sensitivity and resistance of cancer to pharmacological RTK inhibitors is realized.

Oncogenic kinase signalling

How oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity is emphasized and an update is provided on the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signalling in human malignancies.

Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors

It is proposed that paternal age-effect mutations activate a common 'selfish' pathway supporting proliferation in the testis, leading to diverse phenotypes in the next generation including fetal lethality, congenital syndromes and cancer predisposition.

Cell Signaling by Receptor Tyrosine Kinases

...